Catalyst Event
Intuitive Surgical Inc (ISRG) · Other
From KEDI U.S. Medical AI Index (KUSMAI)
3/18/2026, 12:00:00 AM
The U.S. FDA highlighted a company-initiated recall for the 8mm SureForm 30 Gray Reload stapler cartridges due to risks of incomplete staple line formation, which has been associated with four serious injuries and one patient death. Estimated price impact of ~5% due to safety concerns and potential litigation, expected.
Korean Translation
미국 FDA가 불완전한 스테이플 라인 형성 위험으로 인해 회사가 시작한 8mm SureForm 30 그레이 리로드 스테이플러 카트리지에 대한 리콜을 강조함. 해당 문제는 4건의 심각한 부상 및 1건의 환자 사망과 관련이 있으며, 안전 우려 및 잠재적 소송으로 인해 약 5%의 주가 영향이 예상됨.
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
Q1 2026 earnings release scheduled; a price impact of at least 1% is expected.
4/30/2026, 12:00:00 AM
Intuitive Surgical Inc (ISRG) · Earnings Release
Q1 2026 earnings release is scheduled.
4/21/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
New target action date for the FDA's decision on oral obesity drug orforglipron, following an extension of the review period announced on January 15, 2026, scheduled; a price impact of at least 1% is expected.
4/10/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Other
The company is scheduled to present five studies at the 2026 USCAP Annual Meeting from 2026-03-21 to 2026-03-26 scheduled.
3/21/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
Announced positive topline results from the TRANSCEND-T2D-1 Phase 3 trial for its investigational drug retatrutide, which showed significant reductions in A1C and body weight for adults with type 2 diabetes; a price impact of over 10% is estimated.
3/19/2026, 12:00:00 AM
AbbVie Inc (ABBV) · Other
Appeals court ruling on whistleblower lawsuit regarding 340B program overcharging allegations scheduled for March 18, 2026; moderate impact expected from potential legal liabilities, scheduled.
3/18/2026, 12:00:00 AM